Oncology Information System Market

Oncology Information System Market by Product and Service, Application, End User (Hospitals & diagnostic imaging centers, Ablation & Cancer Care Centers, Government Institutions and Research Facilities) - Global Forecast to 2027

Report Code: HIT 3267 Jun, 2022, by marketsandmarkets.com

[351 Pages Report] The oncology information system market includes softwares and services used for comprehensive information and image management that facilitates in the management and optimization of cancer patient profiles & treatment. Patient portfolios are managed by software known as electronic health record (EHR) in healthcare settings such as clinics, hospitals, and research laboratories. These softwares are used to predict treatment outcomes, plan treatment, and exchange cancer patient information across healthcare organizations. These benefits improve the safety and efficacy of cancer treatment for patients. Oncology information system assists physicians and surgeons in selecting the most appropriate therapy to improve the survival rates of cancer patients. The major companies in the oncology information system market includes Siemens Healthineers (Germany), Elekta AB (Sweden), Koninklijke Philips N.V. (Netherlands), McKesson Corporation (US), GE Healthcare (US), Accuray Incorporated (US), Allscripts Healthcare Solutions, Inc. (US).

The global oncology information system market is estimated to grow at a CAGR of 7.6 % during the forecast period. The market is projected to reach USD 11.1 billion by 2027 from USD 7.7 billion in 2022. The growth of this market is primarily driven by factors such as increasing incidence and prevalence of cancer and increasing need to curtail the cost of cancer care and potential benefits offered by oncology information system in treatment, management and planning for cancer care.

In this report, the oncology information system market is segmented based on product and services, application, end user, and region.

Oncology Information System Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the oncology information system Market

The COVID-19 pandemic has led to a global healthcare crisis, resulting in widespread economic impact since January 2020. In Q1 2020, many hospitals and diagnostic imaging centers were functioning in a limited capacity to contain the spread of the virus. At the same time, most patients deferred visits to oncologists, reducing oncology practice revenues in the US by up to 80–90%. This has affected the oncology information system market adversely.

Due to COVID-19, the sales and operating incomes of leading market players dropped. Tight controls over production also resulted in reduced inventory. Oncology research activity in many parts of the world resumed in Q3 2020, resulting in gradual demand growth in the softwares and professional services segment. By August-September 2020, the oncology information system market in North America and Europe had shown considerable recovery. However, the APAC market was still struggling, especially in China and Korea. However, the market is expected to recover fully in the forecast period as the growth drivers for the sotware and services are still intact. The drivers that are expected to boost the market include the prevalence of cancer, and rapid adoption of oncology information system such as electronic medical record (EMR).

The global COVID-19 pandemic has significantly impacted the European oncology information system markets. Due to the pandemic, in April 2021, oncology specialists were seeing 52% fewer patients per week. In June 2021 and after ease of restriction they now seeing 36% fewer patients. For example, at the UK country level, improvements in the number of patients seen per week is noticeably better in June vs April where oncology specialists see 38% fewer patients per week vs 66% per week in April – an improvement of a 28-percentage points.

Furthermore, oncology information system market is led by Siemens Healthineers (Germany), Elekta AB (Sweden), Koninklijke Philips N.V. (Netherlands), McKesson Corporation (US), GE Healthcare (US), Accuray Incorporated (US), Allscripts Healthcare Solutions, Inc. (US) and others.

Oncology information system Market Dynamics

Drivers: Increasing incidence and prevalence of cancer

The major factors attributing to the growth of the oncology information systems market include the rising incidence of cancer cases worldwide. According to GLOBOCAN 2020, there were 19.29 million new cases of cancer worldwide in 2020, and this figure is estimated to reach 28.4 million by 2040 (an increase of 47%). The worldwide prevalence of cancer (5-year prevalence, that is the total number of people living with cancer from the last 5 years) is estimated to be 50.6 million.

Similarly, according to American cancer society, more than 1.9 million new cases of cancer were diagnosed in 2021, in the U.S. alone. A wide range of novel technologies are being developed, which have the potential to overhaul the treatment regime completely. Hence growing prevalence of cancer will support the demand for OIS for streamlining patient information and data management, this will eventually drive the oncology information systems market.

There are few more factors which are playing crucial roles in taking the oncology information system market to the next level, such as increasing need to curtail oncology care cost,  growing adoption of electronic health records (EHR) and other oncology information systems.

Restraints: Dearth of skilled IT professionals in the healthcare industry

The lack of qualified resources is a major barrier in implementing OIS solutions in hospitals. Currently, the demand for healthcare IT professionals far exceeds their supply, not just in developing markets but also in developed markets such as the US and Europe. For instance, as per the 2020 report by the Government of Canada, there is a shortage of IT specialists in healthcare systems across Canada; ~79% of the current clinical IT workers in the country need additional training. The growing number of healthcare IT initiatives further adds to the overall burden.

Opportunities: Growing healthcare IT Industry

The healthcare IT market is projected to reach USD 821.1 billion by 2026 from USD 326.1 billion in 2021. The healthcare IT industry draws lines into several different industries, including medical technology, healthcare, medical devices, and digital health. This industry is disrupting the traditional healthcare delivery model and research systems with the use of modern and advanced technologies.

An integrated healthcare IT environment helps address gaps in the oncology care continuum while reducing ineffective or unnecessary processing steps. It helps eliminate healthcare redundancy, permitting hospital systems to provide patient-centric care across and between healthcare providers. Thus, by deploying various healthcare IT solutions such as EMR, RIS, PACS, VNA, and treatment planning solutions healthcare organizations have reduced their operational costs while providing improved quality of care. This is driving the demand for oncology information system market among major end-user segments.

Challenges: Concerns regarding data privacy

The cases of cyberhacking of healthcare organizations has increased by 42% in 2020 from 2019, according to a report from the tech consulting firm Protenus, which issues an annual Breach Barometer report on the subject. According to this report, there were 470 cases of cyberhacking in 2020 as compared to 330 in 2019. Wide patient information exchanges lead to privacy and security risks and increase the chances of data breaches. In the US, the Identity Theft Resource Center recorded 1,473 breaches in its 2019 breach list, an increase of 17% over the total number of breaches tracked in 2018. The healthcare sector alone accounted for 35.5% of the total tracked breaches. Hence, creating a secure OIS platform is a major challenge faced by vendors catering to the healthcare industry.

Software to account for the largest share of the market during the forecast period

In 2021, the software segment accounted for 83.6% of the oncology information system market for products and services in 2021. The high share of this market segment can be attributed primarily to growing need to control the rising oncology care costs and improve the efficiency of oncology care services by reducing medical errors. Softwares are integral part of any oncology information system and works as interface between database and end user.

Radiation oncology to account for the largest share of the market during the forecast period

The oncology information system market for applications is segmented into radiation oncology, medical oncology and surgical oncology. The radiation oncology segment accounted for 53.8% of the oncology information system market in 2021. The demand for radiation oncology has increased due to increase in the number of radiosurgeries, and a large volume of cancer-related data is being generated at radiological departments.

Hospitals & Diagnostic Imaging Centers to account for the largest share of the market during the forecast period

The oncology information system market by end user is segmented into hospitals & diagnostic imaging centers, ablation & cancer care centers, government institutions and research facilities. The hospitals & diagnostic imaging centers held the largest share of the in application segment of oncology information system market. The increasing adoption of oncology information system at hospital and diagnostic imaging centers due to large amount of data generated during diagnosis and treatment of cancer and significant number of patient submissions/visits every year worldwide, increasing government initiatives aimed at equipping (or upgrading) hospitals with newer and advanced systems are some of the factors responsible for the growth of this segment.

The APAC oncology information system market is projected to grow at the highest rate during the forecast period.

In 2021, the Asia Pacific accounted for 17.8% of the global oncology information system market. The growth of the APAC market is driven by several factors, such as the rising prevalence of cancer, and increasing investment for implementation of IT solutions in healthcare settings. For instance, according to GLOBOCAN, in 2020, 883,395 new cases of cancer were recorded in Japan. The WHO estimates that the incidence of cancer in Japan can rise to 997,537 cases by 2040. The adoption of electronic medical records to use health information big data is a major priority in Japan. According to Japanese government, in 2019 the adoption rate for electronic medical records and ordering systems among hospitals was 34.4% and 43.6% respectively.

Oncology Information System Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Prominent players in the oncology information system market are Koninklijke Philips N.V. (Netherlands), McKesson Corporation (US), Siemens Healthineers (Germany), Elekta AB (Sweden), Epic Systems Corporation (US),  IBM (US), Cerner Corporation (US), Advanced Data Systems (US), Bogardus Medical Systems, Inc (US), F. Hoffmann-La Roche AG (Switzerland), Altai Oncology, LLC. (US), GE Healthcare (US), Accuray Incorporated (US), OPTUM (a part of UnitedHealth Group) (US), Allscripts Healthcare Solutions, Inc. (US), MICA Information Systems, Inc. (US), CureMD Healthcare (US), EndoSoft LLC (US), MIM Software Inc. (US) and RaySearch Laboratories AB (Sweden).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Values (USD Billion)

Segments covered

Product and services, application, end user and Region

Geographies covered

North America, Europe, APAC, Latin America and Middle East and Africa

Companies covered

Koninklijke Philips N.V. (Netherlands), McKesson Corporation (US), Siemens Healthineers (Germany), Elekta AB (Sweden), Epic Systems Corporation (US),  IBM (US), Cerner Corporation (US), Advanced Data Systems (US), Bogardus Medical Systems, Inc (US), F. Hoffmann-La Roche AG (Switzerland), Altai Oncology, LLC. (US), GE Healthcare (US), Accuray Incorporated (US), OPTUM (a part of UnitedHealth Group) (US), Allscripts Healthcare Solutions, Inc. (US), MICA Information Systems, Inc. (US), CureMD Healthcare (US), EndoSoft LLC (US), MIM Software Inc. (US) and RaySearch Laboratories AB (Sweden).

By Product and Service, the oncology information system market is segmented as follows:

  • Software
  • Patient Information Systems
  • Radiology Information systems
  • Oncology Electronic Medical Record (EHR)
  • Laboratory Information Systems
  • Chemotherapy Information System
  • Treatment Planning Systems
  • Clinical Decision Support Systems
  • Radiotherapy Treatment Planning Systems
  • Brachytherapy Treatment Planning Systems
  • Treatment Management Systems & Medical Image Analysis Systems
  • Population Health Management
  • Clinical Integration Solutions
  • Picture archiving and communication System (PACS) & VNA
  • Advanced Visulaization & Image Analysis Solutions
  • Radiation Dose Management Solutions
  • Professional Services
  • Consulting/Optimization Services
  • Implementation Services
  • Post-Sale and Maintenance Services

By Application, the oncology information system market is segmented as follows:

  • Radiation Oncology
  • Medical Oncology
  • Surgical Oncology

By End User, the oncology information system market is segmented as follows:

  • Hospitals & Diagnostic Imaging Centers
  • Ablation  Care Centers and Cancer Care Centers
  • Government Institutions
  • Research Facilities

By Region, the oncology information system market is segmented as follows:

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • ROE
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia 
    • South Korea
    • RoPAC
  • Latin America
    • Brazil
    • Mexico
    • Middle East & Africa

Recent Developments

  • In August 2021, Siemens Healthineers (Germany) completed acquisition of Varian Medical system (UK). this acquisition aimed at creation of a unique, highly integrated portfolio of oncology information system workflow.
  • In June 2021, Koninklijke Philips N.V. (The Netherlands) partnered with Elekta (Sweden) for development of advanced, comprehensive and personalized cancer care through precision oncology information solutions.
  • In December 2020, McKesson Corporation(US) has launched McKesson Corporation has launched Ontada, an oncology technology and insights business dedicated to help advance cancer research and care.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 38)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
                    FIGURE 1 ONCOLOGY INFORMATION SYSTEMS MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
          TABLE 1 STANDARD CURRENCY CONVERSION RATES
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 44)
    2.1 RESEARCH APPROACH
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 SECONDARY RESEARCH
           2.1.3 PRIMARY RESEARCH
                    FIGURE 3 PRIMARY SOURCES
                    2.1.3.1 Key data from primary sources
                                FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS
                    2.1.3.2 Breakdown of primary sources
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 6 PRIMARY SOURCES
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP APPROACH
                    FIGURE 7 ONCOLOGY INFORMATION SYSTEM MARKET: BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN APPROACH
                    FIGURE 8 ONCOLOGY INFORMATION SYSTEMS MARKET: TOP-DOWN APPROACH
                    FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
                    FIGURE 10 ONCOLOGY INFORMATION SYSTEM MARKET (2021): SUPPLY-SIDE MARKET SIZE ESTIMATION
                    FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
                    FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ONCOLOGY INFORMATION SYSTEMS MARKET (2022–2027)
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
          FIGURE 13 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 RISK ASSESSMENT
          TABLE 2 RISK ASSESSMENT: ONCOLOGY INFORMATION SYSTEMS MARKET

3 EXECUTIVE SUMMARY (Page No. - 58)
    FIGURE 14 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
    FIGURE 15 ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 16 PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 17 TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 18 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 19 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 20 ONCOLOGY INFORMATION SYSTEM MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 21 ONCOLOGY INFORMATION SYSTEM MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 22 GEOGRAPHICAL SNAPSHOT OF THE ONCOLOGY INFORMATION SYSTEMS MARKET

4 PREMIUM INSIGHTS (Page No. - 68)
    4.1 ONCOLOGY INFORMATION SYSTEM MARKET OVERVIEW
          FIGURE 23 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
    4.2 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE (2022–2027)
          FIGURE 24 CONSULTING & OPTIMIZATION SERVICES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
    4.3 APAC: ONCOLOGY INFORMATION SYSTEM MARKET SHARE, BY APPLICATION AND COUNTRY (2021)
          FIGURE 25 RADIATION ONCOLOGY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
    4.4 ONCOLOGY INFORMATION SYSTEM MARKET: DEVELOPED VS. DEVELOPING MARKETS (USD MILLION)
          FIGURE 26 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
    4.5 ONCOLOGY INFORMATION SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 27 CHINA TO WITNESS HIGHEST GROWTH FROM 2022 TO 2027

5 MARKET OVERVIEW (Page No. - 73)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 28 ONCOLOGY INFORMATION SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Need to curtail oncology care costs
                                FIGURE 29 GLOBAL ONCOLOGY SPENDING, 2015–2021 (USD BILLION)
                    5.2.1.2 Growing adoption of EHRs and other oncology healthcare IT solutions to improve care quality
                                FIGURE 30 PERCENTAGE OF PRIMARY CARE PHYSICIANS IN SELECTED COUNTRIES USING ELECTRONIC MEDICAL RECORDS (2019)
                    5.2.1.3 Increasing incidence and prevalence of cancer
                                TABLE 3 CANCER INCIDENCE PER MILLION POPULATION, BY COUNTRY, 2016–2020
                    5.2.1.4 Favorable government mandates and support for oncology information systems
                    5.2.1.5 Potential benefits of and technological advancements in oncology information systems
           5.2.2 RESTRAINTS
                    5.2.2.1 Interoperability issues
                    5.2.2.2 Dearth of skilled IT professionals in healthcare industry
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing healthcare IT Industry
                    5.2.3.2 Integration of EMR with treatment planning systems
           5.2.4 CHALLENGES
                    5.2.4.1 Concerns regarding data privacy

6 INDUSTRY INSIGHTS (Page No. - 83)
    6.1 INTRODUCTION
    6.2 TECHNOLOGY ANALYSIS: ONCOLOGY INFORMATION SYSTEMS
           6.2.1 ARTIFICIAL INTELLIGENCE
           6.2.2 MACHINE LEARNING
           6.2.3 INTERNET OF THINGS
           6.2.4 BLOCKCHAIN
    6.3 PRICING ANALYSIS: ONCOLOGY INFORMATION SYSTEMS
    6.4 ECOSYSTEM LANDSCAPE: ONCOLOGY INFORMATION SYSTEM MARKET
          FIGURE 31 ONCOLOGY INFORMATION SYSTEMS MARKET: ECOSYSTEM
    6.5 REGULATORY ANALYSIS
           6.5.1 NORTH AMERICA
           6.5.2 EUROPE
           6.5.3 ASIA PACIFIC
           6.5.4 MIDDLE EAST & AFRICA
           6.5.5 LATIN AMERICA
    6.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 7 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 8 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    6.7 PORTER’S FIVE FORCES ANALYSIS
          FIGURE 32 DEGREE OF COMPETITION IS HIGH IN THE ONCOLOGY INFORMATION SYSTEM MARKET
          TABLE 9 ONCOLOGY INFORMATION SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS
           6.7.1 THREAT OF NEW ENTRANTS
           6.7.2 THREAT OF SUBSTITUTES
           6.7.3 BARGAINING POWER OF SUPPLIERS
           6.7.4 BARGAINING POWER OF BUYERS
           6.7.5 INTENSITY OF COMPETITIVE RIVALRY
    6.8 KEY STAKEHOLDERS & BUYING CRITERIA
           6.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    FIGURE 33 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR ONCOLOGY INFORMATION SYSTEMS
                    TABLE 10 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
    6.9 KEY BUYING CRITERIA BY END USERS
          FIGURE 34 BUYING CRITERIA OF END USERS
          TABLE 11 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
    6.10 PATENT ANALYSIS
           6.10.1 PATENT PUBLICATION TRENDS FOR ONCOLOGY INFORMATION SYSTEMS
                     FIGURE 35 GLOBAL PATENT PUBLICATION TRENDS IN ONCOLOGY INFORMATION SYSTEMS MARKET, 2018–2022
           6.10.2 TOP APPLICANTS (COMPANIES) FOR ONCOLOGY INFORMATION SYSTEM PATENTS
                     FIGURE 36 TOP COMPANIES THAT APPLIED FOR ONCOLOGY INFORMATION SYSTEM PATENTS, 2018–2022
    6.11 KEY CONFERENCES & EVENTS IN 2022-2023
           TABLE 12 ONCOLOGY INFORMATION SYSTEMS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
    6.12 COVID-19 IMPACT ON ONCOLOGY INFORMATION SYSTEM MARKET

7 ONCOLOGY INFORMATION SYSTEM MARKET, BY PRODUCT & SERVICE (Page No. - 100)
    7.1 INTRODUCTION
          TABLE 13 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
    7.2 SOFTWARE
          TABLE 14 ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 15 ONCOLOGY INFORMATION SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.1 PATIENT INFORMATION SYSTEMS
                    TABLE 16 PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 17 PATIENT INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.1.1 Oncology electronic medical records
                               7.2.1.1.1 Adoption of oncology electronic medical records is growing significantly in emerging countries
                                              TABLE 18 KEY PLAYERS OFFERING ONCOLOGY ELECTRONIC MEDICAL RECORDS
                                              TABLE 19 ONCOLOGY ELECTRONIC MEDICAL RECORDS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.1.2 Laboratory information systems
                               7.2.1.2.1 Need for accurate, efficient, and rapid transfer of lab results across networks to drive market growth
                                              TABLE 20 KEY PLAYERS OFFERING LABORATORY INFORMATION SYSTEMS
                                              TABLE 21 LABORATORY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.1.3 Radiology information systems
                               7.2.1.3.1 Integration of RIS with HIS and PACS has attracted attention from stakeholders
                                              TABLE 22 KEY PLAYERS OFFERING RADIOLOGY INFORMATION SYSTEMS
                                              TABLE 23 RADIOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.1.4 Chemotherapy information systems
                               7.2.1.4.1 Chemotherapy is increasingly being adopted as primary mode of treatment for various cancer types
                                              TABLE 24 KEY PLAYERS OFFERING CHEMOTHERAPY INFORMATION SYSTEMS
                                              TABLE 25 CHEMOTHERAPY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.2 TREATMENT PLANNING SYSTEMS
                    TABLE 26 TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 27 TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.2.1 Radiotherapy treatment planning systems
                               7.2.2.1.1 Radiotherapy treatment planning systems to witness increased adoption for treatment of deep-seated tumors
                                              TABLE 28 KEY MARKET PLAYERS OFFERING RADIOTHERAPY TREATMENT PLANNING SOLUTIONS
                                              TABLE 29 RADIOTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.2.2 Clinical decision support systems
                               7.2.2.2.1 Need to minimize errors and ensure regulatory compliance to drive adoption of CDSS
                                              TABLE 30 KEY PLAYERS OFFERING CLINICAL DECISION SUPPORT SYSTEMS
                                              TABLE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.2.3 Brachytherapy treatment planning systems
                               7.2.2.3.1 Better patient care with pulsed-dose rate brachytherapy to drive demand for these systems
                                              TABLE 32 BRACHYTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.3 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS
                    TABLE 33 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 34 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.3.1 Population health management solutions
                               7.2.3.1.1 PHM solutions aggregate and provide wide range of cancer data for providers
                                              TABLE 35 KEY PLAYERS OFFERING POPULATION HEALTH MANAGEMENT SOLUTIONS
                                              TABLE 36 POPULATION HEALTH MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.3.2 Clinical integration solutions
                               7.2.3.2.1 Increasing number of cancer patient admissions in inpatient facilities is key factor driving market growth
                                              TABLE 37 KEY PLAYERS OFFERING CLINICAL INTEGRATION SOLUTIONS
                                              TABLE 38 CLINICAL INTEGRATION SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.3.3 Picture archiving and communication systems & vendor-neutral archive solutions
                               7.2.3.3.1 Rising demand for PACS and increasing generation of image data will ensure sustained demand for these solutions
                                              TABLE 39 KEY PLAYERS OFFERING PICTURE ARCHIVING AND COMMUNICATION SYSTEMS & VENDOR-NEUTRAL ARCHIVE SOLUTIONS
                                              TABLE 40 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS & VENDOR-NEUTRAL ARCHIVE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.3.4 Advanced visualization & image analysis solutions
                               7.2.3.4.1 Increasing demand for imaging modalities in various indications of oncology to drive segment growth
                                              TABLE 41 ADVANCED VISUALIZATION & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.3.5 Radiation dose management solutions
                               7.2.3.5.1 Use of these solutions enables optimization of radiation dose administration and management
                                              TABLE 42 KEY PLAYERS OFFERING RADIATION DOSE MANAGEMENT SOLUTIONS
                                              TABLE 43 RADIATION DOSE MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 PROFESSIONAL SERVICES
          TABLE 44 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 45 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.3.1 IMPLEMENTATION SERVICES
                    7.3.1.1 Healthcare organizations are increasingly outsourcing implementation services
                                TABLE 46 KEY PLAYERS OFFERING IMPLEMENTATION SERVICES
                                TABLE 47 IMPLEMENTATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.3.2 POST-SALE & MAINTENANCE SERVICES
                    7.3.2.1 Rising trend of outsourcing is driving market for post-sale & maintenance services
                                TABLE 48 KEY PLAYERS OFFERING POST-SALE & MAINTENANCE SERVICES
                                TABLE 49 POST-SALE & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.3.3 CONSULTING & OPTIMIZATION SERVICES
                    7.3.3.1 Consulting services deliver optimum guidance to healthcare providers for implementing oncology information solutions
                                TABLE 50 KEY PLAYERS OFFERING CONSULTING SERVICES
                                TABLE 51 CONSULTING & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

8 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION (Page No. - 139)
    8.1 INTRODUCTION
          TABLE 52 ONCOLOGY INFORMATION SYSTEM MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.2 RADIATION ONCOLOGY
           8.2.1 INTRODUCTION OF AI-BASED RADIOTHERAPY TREATMENT PLANNING SYSTEMS TO DRIVE MARKET GROWTH
                    TABLE 53 US: RADIATION-TREATED CANCER SURVIVORS, 2016–2030 (THOUSAND)
                    TABLE 54 KEY PRODUCTS IN RADIATION ONCOLOGY MARKET
                    TABLE 55 ONCOLOGY INFORMATION SYSTEM MARKET FOR RADIATION ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 MEDICAL ONCOLOGY
           8.3.1 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
                    TABLE 56 KEY PRODUCTS IN MEDICAL ONCOLOGY MARKET
                    FIGURE 37 NUMBER OF ONCOLOGY CLINICAL TRIALS WORLDWIDE, 2012–2018
                    TABLE 57 ONCOLOGY INFORMATION SYSTEM MARKET FOR MEDICAL ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
    8.4 SURGICAL ONCOLOGY
           8.4.1 NEED FOR STRUCTURED HEALTHCARE INFORMATION SYSTEMS TO BOOST MARKET GROWTH
                    TABLE 58 KEY PRODUCTS IN SURGICAL ONCOLOGY MARKET
                    TABLE 59 ONCOLOGY INFORMATION SYSTEM MARKET FOR SURGICAL ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)

9 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER (Page No. - 147)
    9.1 INTRODUCTION
          TABLE 60 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.2 HOSPITALS & DIAGNOSTIC IMAGING CENTERS
           9.2.1 HOSPITALS & DIAGNOSTIC IMAGING CENTERS ARE LARGEST END USERS OF ONCOLOGY INFORMATION SYSTEMS
                    TABLE 61 NUMBER OF HOSPITALS, BY COUNTRY (2021)
                    TABLE 62 ONCOLOGY INFORMATION SYSTEM MARKET FOR HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
    9.3 ABLATION & CANCER CARE CENTERS
           9.3.1 INITIATION OF CANCER CARE PROGRAMS AND SUPPORTING REIMBURSEMENT PLANS TO BOOST SEGMENT GROWTH
                    TABLE 63 ONCOLOGY INFORMATION SYSTEM MARKET FOR ABLATION & CANCER CARE CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
    9.4 GOVERNMENT INSTITUTES
           9.4.1 RISING GOVERNMENT INITIATIVES TO DRIVE MARKET GROWTH
                    TABLE 64 ONCOLOGY INFORMATION SYSTEM MARKET FOR GOVERNMENT INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
    9.5 RESEARCH FACILITIES
           9.5.1 GROWING NUMBER OF CANCER RESEARCH STUDIES TO DRIVE MARKET GROWTH
                    TABLE 65 ONCOLOGY INFORMATION SYSTEMS MARKET FOR RESEARCH FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)

10 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION (Page No. - 155)
     10.1 INTRODUCTION
             FIGURE 38 ONCOLOGY INFORMATION SYSTEM MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
             TABLE 66 ONCOLOGY INFORMATION SYSTEM MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA
             FIGURE 39 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEM MARKET SNAPSHOT
             TABLE 67 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEM MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 68 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
             TABLE 69 NORTH AMERICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 70 NORTH AMERICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 71 NORTH AMERICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 72 NORTH AMERICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 73 NORTH AMERICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 74 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 75 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Rising adoption of oncology information systems in hospitals to drive market growth
                                      FIGURE 40 US: HOSPITAL EHR ADOPTION (2010–2018)
                                      TABLE 76 US: KEY MACROINDICATORS
                                      TABLE 77 US: ONCOLOGY INFORMATION SYSTEM MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 78 US: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 79 US: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 80 US: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 81 US: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 82 US: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Deployment of digital healthcare initiatives is boosting market growth in Canada
                                      FIGURE 41 CANADA: EMR ADOPTION BY PRIMARY CARE PHYSICIANS, 2013–2018
                                      TABLE 83 CANADA: KEY MACROINDICATORS
                                      TABLE 84 CANADA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 85 CANADA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 86 CANADA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 87 CANADA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 88 CANADA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 89 CANADA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
     10.3 EUROPE
             FIGURE 42 EUROPE: CANCER PREVALENCE, BY COUNTRY, 2012–2030
             TABLE 90 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 91 EUROPE: ONCOLOGY INFORMATION SYSTEM MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
             TABLE 92 EUROPE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 93 EUROPE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 94 EUROPE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 95 EUROPE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 96 EUROPE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 97 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 98 EUROPE: ONCOLOGY INFORMATION SYSTEM MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 High adoption of EHR systems among healthcare practitioners to drive market growth in Germany
                                      TABLE 99 GERMANY: KEY MACROINDICATORS
                                      TABLE 100 GERMANY: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 101 GERMANY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 102 GERMANY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 103 GERMANY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 104 GERMANY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 105 GERMANY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 UK is rapidly transforming its organizations into paperless environments through EHRs
                                      TABLE 106 UK: KEY MACROINDICATORS
                                      TABLE 107 UK: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 108 UK: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 109 UK: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 110 UK: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 111 UK: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 112 UK: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Growing reforms in digital health will support market growth
                                      TABLE 113 FRANCE: KEY MACROINDICATORS
                                      TABLE 114 FRANCE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 115 FRANCE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 116 FRANCE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 117 FRANCE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 118 FRANCE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 119 FRANCE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Increasing government initiatives and reforms to drive market growth
                                      TABLE 120 ITALY: KEY MACROINDICATORS
                                      TABLE 121 ITALY: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 122 ITALY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 123 ITALY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 124 ITALY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 125 ITALY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 126 ITALY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Increasing prevalence of cancer to drive adoption of oncology information systems
                                      TABLE 127 SPAIN: KEY MACROINDICATORS
                                      TABLE 128 SPAIN: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 129 SPAIN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 130 SPAIN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 131 SPAIN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 132 SPAIN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 133 SPAIN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 134 ROE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                        TABLE 135 ROE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 136 ROE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 137 ROE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 138 ROE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 139 ROE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
     10.4 ASIA PACIFIC
             FIGURE 43 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET SNAPSHOT
             TABLE 140 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEM MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 141 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEM MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
             TABLE 142 ASIA PACIFIC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 143 ASIA PACIFIC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 144 ASIA PACIFIC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 145 ASIA PACIFIC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 146 ASIA PACIFIC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 147 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEM MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 148 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEM MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Japan dominates Asia Pacific oncology information systems market
                                      TABLE 149 JAPAN: KEY MACROINDICATORS
                                      TABLE 150 JAPAN: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 151 JAPAN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 152 JAPAN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 153 JAPAN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 154 JAPAN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 155 JAPAN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Strong government support in China to propel market growth
                                      TABLE 156 CHINA: KEY MACROINDICATORS
                                      TABLE 157 CHINA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 158 CHINA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 159 CHINA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 160 CHINA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 161 CHINA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 162 CHINA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Rising need for cost-effective technologies has increased demand for oncology information solutions in India
                                      TABLE 163 INDIA: KEY MACROINDICATORS
                                      TABLE 164 INDIA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 165 INDIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 166 INDIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 167 INDIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 168 INDIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 169 INDIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             10.4.4 AUSTRALIA
                        10.4.4.1 Supportive government initiatives and strategic developments by market players to drive market growth
                                      TABLE 170 AUSTRALIA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 171 AUSTRALIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 172 AUSTRALIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 173 AUSTRALIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 174 AUSTRALIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 175 AUSTRALIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             10.4.5 SOUTH KOREA
                        10.4.5.1 Increasing adoption of oncology information systems to positively impact market growth
                                      TABLE 176 SOUTH KOREA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 177 SOUTH KOREA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 178 SOUTH KOREA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 179 SOUTH KOREA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 180 SOUTH KOREA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 181 SOUTH KOREA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
                        TABLE 182 ROAPAC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                        TABLE 183 ROAPAC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 184 ROAPAC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 185 ROAPAC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 186 ROAPAC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 187 ROAPAC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
     10.5 LATIN AMERICA
             TABLE 188 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 189 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEM MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
             TABLE 190 LATIN AMERICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 191 LATIN AMERICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 192 LATIN AMERICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 193 LATIN AMERICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 194 LATIN AMERICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 195 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 196 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEM MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 Modernization of healthcare infrastructure to drive market growth
                                      TABLE 197 BRAZIL: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 198 BRAZIL: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 199 BRAZIL: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 200 BRAZIL: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 201 BRAZIL: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 202 BRAZIL: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             10.5.2 MEXICO
                        10.5.2.1 Favorable government initiatives and growing medical tourism to drive market growth
                                      TABLE 203 MEXICO: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                      TABLE 204 MEXICO: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 205 MEXICO: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 206 MEXICO: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 207 MEXICO: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 208 MEXICO: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA
                        TABLE 209 ROLATAM: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                        TABLE 210 ROLATAM: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 211 ROLATAM: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 212 ROLATAM: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 213 ROLATAM: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 214 ROLATAM: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
                        TABLE 215 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                        TABLE 216 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 217 MIDDLE EAST & AFRICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 218 MIDDLE EAST & AFRICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 219 MIDDLE EAST & AFRICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 220 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 221 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 222 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 253)
     11.1 OVERVIEW
     11.2 KEY DEVELOPMENTS BY LEADING PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET, JANUARY 2018–APRIL 2022
     11.3 KEY PLAYER STRATEGIES/RIGHT TO WIN
     11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
             FIGURE 44 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
             TABLE 223 ONCOLOGY INFORMATION SYSTEMS MARKET: DEGREE OF COMPETITION
     11.5 MARKET RANKING ANALYSIS
             FIGURE 45 RANK OF COMPANIES IN GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET (2021)
     11.6 COMPETITIVE LEADERSHIP MAPPING
             11.6.1 STARS
             11.6.2 EMERGING LEADERS
             11.6.3 PERVASIVE PLAYERS
             11.6.4 PARTICIPANTS
                        FIGURE 46 ONCOLOGY INFORMATION SYSTEMS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
     11.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 STARTING BLOCKS
             11.7.3 RESPONSIVE COMPANIES
             11.7.4 DYNAMIC COMPANIES
                       FIGURE 47 ONCOLOGY INFORMATION SYSTEMS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)
     11.8 COMPETITIVE BENCHMARKING
             TABLE 224 ONCOLOGY INFORMATION SYSTEMS MARKET: SUPPORTING DATA OF KEY START-UPS/SMES
     11.9 COMPETITIVE BENCHMARKING FOR STARTUPS/SMES
             TABLE 225 ONCOLOGY INFORMATION SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
     11.10 ONCOLOGY INFORMATION SYSTEMS MARKET: R&D EXPENDITURE
              FIGURE 48 R&D EXPENDITURE OF KEY PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET (2020 VS. 2021)
     11.11 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS
              FIGURE 49 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET
     11.12 COMPANY REGIONAL FOOTPRINT
              TABLE 226 COMPANY REGIONAL FOOTPRINT
              TABLE 227 COMPANY SOFTWARE FOOTPRINT
              TABLE 228 COMPANY SERVICE FOOTPRINT
              TABLE 229 COMPANY APPLICATION FOOTPRINT
     11.13 COMPETITIVE SITUATION AND TRENDS
             11.13.1 PRODUCT LAUNCHES
                        TABLE 230 ONCOLOGY INFORMATION SYSTEMS MARKET: KEY PRODUCT LAUNCHES
             11.13.2 DEALS
                        TABLE 231 ONCOLOGY INFORMATION SYSTEMS MARKET: KEY DEALS
             11.13.3 OTHER DEVELOPMENTS
                        TABLE 232 ONCOLOGY INFORMATION SYSTEMS MARKET: OTHER KEY DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 272)
     12.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             12.1.1 KONINKLIJKE PHILIPS N.V.
                        TABLE 233 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
                        FIGURE 50 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
             12.1.2 SIEMENS HEALTHINEERS
                        TABLE 234 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
                        FIGURE 51 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2021)
             12.1.3 ELEKTA
                        TABLE 235 ELEKTA: BUSINESS OVERVIEW
                        FIGURE 52 ELEKTA: COMPANY SNAPSHOT (2021)
             12.1.4 GE HEALTHCARE
                        TABLE 236 GE HEALTHCARE: BUSINESS OVERVIEW
                        FIGURE 53 GE HEALTHCARE: COMPANY SNAPSHOT (2021)
             12.1.5 MCKESSON CORPORATION
                        TABLE 237 MCKESSON CORPORATION: BUSINESS OVERVIEW
                        FIGURE 54 MCKESSON CORPORATION: COMPANY SNAPSHOT (2021)
     12.2 OTHER PLAYERS
             12.2.1 CERNER CORPORATION
                        TABLE 238 CERNER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 55 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
             12.2.2 ACCURAY INCORPORATED
                        TABLE 239 ACCURAY INCORPORATED: BUSINESS OVERVIEW
                        FIGURE 56 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2021)
             12.2.3 ALLSCRIPTS HEALTHCARE, LLC
                        TABLE 240 ALLSCRIPTS HEALTHCARE, LLC.: BUSINESS OVERVIEW
                        FIGURE 57 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
             12.2.4 IBM
                        TABLE 241 IBM: BUSINESS OVERVIEW
                        FIGURE 58 IBM: COMPANY SNAPSHOT (2021)
             12.2.5 F. HOFFMANN-LA ROCHE AG
                        TABLE 242 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
                        FIGURE 59 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2021)
             12.2.6 EPIC SYSTEMS CORPORATION
                        TABLE 243 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
             12.2.7 RAYSEARCH LABORATORIES
                        TABLE 244 RAYSEARCH LABORATORIES: BUSINESS OVERVIEW
                        FIGURE 60 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2021)
             12.2.8 CUREMD HEALTHCARE
                        TABLE 245 CUREMD HEALTHCARE: BUSINESS OVERVIEW
             12.2.9 BOGARDUS MEDICAL SYSTEMS, INC.
                        TABLE 246 BOGARDUS MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
             12.2.10 OPTUM (UNITEDHEALTH GROUP)
                        TABLE 247 OPTUM: BUSINESS OVERVIEW
                        FIGURE 61 OPTUM: COMPANY SNAPSHOT (2021)
             12.2.11 MICA INFORMATION SYSTEMS, INC.
                        TABLE 248 MICA INFORMATION SYSTEMS, INC.: BUSINESS OVERVIEW
             12.2.12 ADVANCED DATA SYSTEMS
                        TABLE 249 ADVANCED DATA SYSTEMS: BUSINESS OVERVIEW
             12.2.13 ENDOSOFT LLC
                        TABLE 250 ENDOSOFT LLC: BUSINESS OVERVIEW
             12.2.14 ALTAI ONCOLOGY, LLC
                        TABLE 251 ALTAI ONCOLOGY, LLC: BUSINESS OVERVIEW
             12.2.15 MIM SOFTWARE INC.
                        TABLE 252 MIM SOFTWARE INC.: BUSINESS OVERVIEW

*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 341)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This research study involved the extensive use of secondary sources, directories, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva) to identify and collect information useful to the study. Primary sources were several industry experts from core and related industries and preferred suppliers, manufacturers, distributors, service providers, and technology developers. Primary sources also included standard and certification organizations from companies and organizations related to all segments of this industry’s value chain.

Secondary Research

This research study involved widespread secondary sources; directories; databases such as D&B, Bloomberg Business, and Factiva; white papers; annual reports; and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the oncology information system market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research. These secondary sources include World Health Organization (WHO), FDI World Dental Federation, International Federation of Endodontic Association (IFEA), National Dental Association (NDA), American Dental Association (ADA), Canadian Dental Association (CDA), Association for Dental Education in Europe (ADEE), European Association of Dental Public Health (EADPH), European Society of Cosmetic Dentistry (ESCD), European Academy of Esthetic Dentistry (EAED), British Dental Association (BDA), French Dental Association (FDA) (Association Dentaire Franηaise), Asia Pacific Dental Federation (APDF), Japan Dental Association (JDA), Australian Dental Prosthetics Association (ADPA), Indian Dental Association (IDA), 3D Printing Association Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, market classification, and segmentation according to industry trends to the bottom-most level and regional markets. It was also used to obtain information about the key developments from a market-oriented perspective.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies operating in the oncology information system market. The primary sources from the demand side include oncology information system, dental lab groups, laboratory technicians, dental lab directors, traditional laboratories, and digital laboratories. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Given below is the breakdown of primary respondents:

Oncology Information System Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches have been used to estimate and validate the size of the oncology information system market and other dependent submarkets.

The research methodology used to estimate the market size includes the following details:

  • The market value of software such as patient information system, treatment planning system, treatment management system and medical image analysis system has been extracted from the repository and validated through secondary and primary research.
  • Oncology information system services market shares have been extracted from the repository and validated through secondary and primary research.
  • The market shares of the application segments have been extracted from the repository and validated through secondary and primary research.
  • This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives.
  • The bottom-up approach has been applied to different regions and other segments of the oncology information system market. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
  • This data is consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Approach to calculate the revenue of different players in the Oncology information system market

In this report, the global oncology information system market size was arrived at by using the revenue share analysis of leading players. For this purpose, major players in the market were identified, and their revenues from the oncology information system business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key market players’ marketing executives.

Approach to derive the market size and estimate market growth

The total size of the oncology information system market was arrived at after data triangulation from three different approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from the demand and supply sides.

Bottom-up Approach: In this report, the global market size was arrived at using the revenue share analysis of leading players in the indirect restorative materials and lab equipment market. Wherever feasible, revenue share analysis was also employed to determine segmental market size by identifying leading players for the respective industry programs. For this purpose, major players in the market were identified through secondary research, and their revenues from the oncology information systemmaterials and equipment business were determined through various insights gathered during the primary and secondary research. Secondary research included studying the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders such as CEOs, directors, and marketing executives of key market players.

Top-up Approach: The overall oncology information system market size was used in the top-down approach to estimate the sizes of other individual markets (product and services, application, end user and region) through percentage splits from secondary and primary research. To calculate each type of specific market segment, the most appropriate, immediate parent market size was used to implement the top-down approach. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues.

Geographic market assessment (by region & country): The geographic assessment was conducted using the following approaches:

  • Approach 1: The geographic revenue contributions/splits of leading players in the product and services market (wherever available) and respective growth trends.
  • Approach 2: Geographic adoption trends for individual application segments for the demand side and growth prospects for each segment (assumptions and indicative estimates validated from primary interviews).
  • Approach 3: Geographic market size of end user and growth prospects for each segment (assumptions and indicative estimates validated from primary interviews).

Report Objectives

  • To define, describe, and forecast the global oncology information system market based on product and services, application, end user and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall oncology information system market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for key market players
  • To forecast the size of the oncology information system market with respect to five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
  • To profile the key players in the global oncology information system market and comprehensively analyze their core competencies2 and market shares in terms of key market developments, product portfolios, and financials
  • To track and analyze competitive developments such as mergers and acquisitions, expansions, partnerships, product launches, collaborations, and agreements of leading players in the global oncology information system market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product Matrix: Detailed comparison of the product portfolios of the top companies
Oncology Information System Market Size,  Share & Growth Report
Report Code
HIT 3267
Published ON
Jun, 2022
Choose License Type
BUY NOW
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status